VIRACEPT 250 mg
Generic Name: nelfinavir
Pill imprint VIRACEPT 250 mg has been identified as Viracept 250 mg.
Viracept is used in the treatment of hiv infection; occupational exposure; nonoccupational exposure and belongs to the drug class protease inhibitors. There is no proven risk in humans during pregnancy.
Viracept 250 mg is not subject to the Controlled Substances Act.
See also related documents.
Viracept Images
- Generic Name:
- nelfinavir
- Imprint:
-
VIRACEPT
250 mg - Strength:
- 250 mg
- Color:
- Blue
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Inactive Ingredients:
- calcium silicate
crospovidone
magnesium stearate
hypromelloses
triacetin
FD&C Blue No. 2
- Drug Class:
- Protease inhibitors
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- ViiV Healthcare
- National Drug Code (NDC):
- 63010-0010
| NDC Code | Manufacturer / Repackager |
|---|---|
| 54868-3947 | Physicians Total Care Inc (repackager) |
| 55289-0477 | PDRX Pharmaceuticals Inc (repackager) |
| 54569-4543 | A S Medication Solutions LLC (repackager) |
| 52959-0289 | H.J. Harkins Company, Inc (repackager) |
| 49999-0431 | Lake Erie Medical and Surgical Supply (repackager) |
| 66267-0514 | Nucare Pharmaceuticals Inc (repackager) |
Note: Inactive ingredients may vary.
Advertisement
More Viracept resources
Search Again
